NOTICE OF INTENT FOR ENTERPRISE TRUSTED SSL ANNUAL SERVICE SUBSCRIPTION
ID: NOI-NIAID-25-2243451Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Software Publishers (513210)

PSC

IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A21)

Original Source

https://sam.gov/opp/51bef887010a443bba8ec4ba44209461/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with HID Global dba HydrantID for an annual renewal subscription of an Enterprise Trusted SSL license. This procurement is essential for maintaining secure communications and data integrity within the agency, reflecting the critical nature of SSL services in safeguarding sensitive information. The period of performance for this contract is set from December 15, 2024, to December 14, 2025, with interested vendors required to submit capability statements and letters of authorization to resell by 10:00 am on October 31, 2024, via the NIAID's electronic Simplified Acquisition Submission System (eSASS). For further inquiries, vendors may contact Leah Hinson at leah.hinson@nih.gov.

    Point(s) of Contact
    Leah Hinson
    leah.hinson@nih.gov
    Files
    Title
    Posted
    2_2243451_NOI.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) issued a Pre-Solicitation Notice indicating its intent to negotiate a sole source agreement with HID Global dba HydrantID for an annual renewal subscription of an Enterprise Trusted SSL license. The period of performance for this agreement is set from December 15, 2024, to December 14, 2025, at the NIAID location in Rockville, Maryland. The authority for this sole source requirement is grounded in federal statute 41 U.S.C. 1901 (a) (1) and the Federal Acquisition Regulation (FAR) 13.106-1, which applies when only one responsible source can fulfill the agency's needs. Interested responsible parties may submit capability statements and letters of authorization to resell by 10:00 am on October 31, 2024, via the NIAID's electronic Simplified Acquisition Submission System (eSASS). However, this notice emphasizes it is not a Request for Proposal, and the decision not to proceed with competitive bidding will rest solely with the government. Overall, this document outlines a specific procurement intention while providing a framework for potential vendor engagement.
    Lifecycle
    Title
    Type
    NOTICE OF INTENT FOR ENTERPRISE TRUSTED SSL ANNUAL SERVICE SUBSCRIPTION
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent to Sole Source; Infor Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Infor (US), LLC for the maintenance software license, maintenance, and support of Infor / Lawson Applications at the NIH Clinical Center in Bethesda, Maryland. This acquisition is crucial for ensuring the continued operation and support of various software modules utilized within the NIH, including financial management and inventory control systems, which are essential for the center's clinical and administrative functions. The contract will be awarded under the Federal Acquisition Regulation (FAR) Part 13, with a total value not exceeding $7.5 million, and interested parties may submit their capabilities and interest to the primary contact, Kristin Nagashima, via email by November 1, 2024, at 10 AM EST.
    Renewal of maintenance/service agreement for medical diagnostic imaging equipment
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with Philips North America LLC for the renewal of a maintenance/service agreement for medical diagnostic imaging equipment at the Integrated Research Facility (IRF) in Frederick, Maryland. This agreement is crucial for maintaining the operational integrity of specialized imaging equipment, including a Magnetic Resonance 3T Achieva and associated workstations, which are essential for conducting biodefense research involving high-consequence infectious diseases. The contract is set to cover the period from January 18, 2025, to December 31, 2025, coinciding with the end of the equipment's life cycle, and interested vendors may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by October 25, 2024, at 5:00 PM ET. For further inquiries, contact Dana Monroe at dana.monroe@nih.gov or call 406-375-9814.
    Access to Elsevier’s “Science Direct” On-Line Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide continued access to Elsevier’s ScienceDirect, Embase, and Reaxys online services. The objective is to ensure NIH and HHS staff have uninterrupted access to a wide range of electronic journals and databases, which are critical for their research and administrative functions. This contract will support the NIH Library's mission by enhancing access to scientific literature, thereby improving productivity and efficiency among researchers and clinicians. Interested organizations must submit their capability statements by November 6, 2024, at 10 A.M. EST, and can direct inquiries to Oghogho Joy Ajao at ajaooj@mail.nih.gov.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    NextSeq 2000 Silver Support Plan
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to procure a NextSeq 2000 Silver Support Plan from Illumina, Inc. This procurement is essential for maintaining high throughput sequencing capabilities that are critical for research into immune responses against infectious diseases, particularly through RNA sequencing methods. The support plan includes comprehensive service coverage, preventive maintenance, remote technical support, and timely on-site response during the performance period from November 1, 2024, to July 4, 2025. Interested parties must submit capability statements by October 28, 2024, to Angela Puddy at angela.puddy@nih.gov, as this is not a request for proposals and the Government retains discretion regarding competition for this requirement.
    Notice of Intent to Sole Source; 3M Health Information Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to 3M Health Information Systems for the acquisition of the 360 Encompass application. This procurement aims to replace the existing 3M Clinical Abstracting (ClinTrac) system, which is being phased out by the vendor, ensuring continuity in health information management services. The 360 Encompass application is critical for clinical documentation improvement, coding excellence, and computer-assisted coding, and it integrates seamlessly with the NIH's existing infrastructure, minimizing additional costs and implementation time associated with switching vendors. Interested parties may submit their capabilities and interest to Kristin Nagashima at kristin.nagashima@nih.gov by November 6, 2024, at 3 PM EST.
    CareDX Lab Solutions Inc. Allo Seq Tx17 Next Generation Sequencing (NGS) Reagent Kits
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to CareDx Lab Solutions Inc. for the procurement of Allo Seq Tx17 Next Generation Sequencing (NGS) reagent kits. This acquisition aims to secure a one-year supply of NGS reagents necessary for the Human Leukocyte Antigen (HLA) Laboratory within the Department of Transfusion Medicine, ensuring adequate stock for patient testing through quarterly shipments scheduled from November 2024 to August 2025. The HLA Laboratory plays a critical role in providing diagnostic testing and consultations for transplant eligibility, maintaining accreditation, and engaging in research for new diagnostic tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by October 30, 2024, at 6:30 AM EST, as this is not a request for proposals.
    Gibco EXPI293 Expression Media 6 x 1L, catalog # A1435102 and 2) EXPIFECTAMINE TRANSFXN KIT 10L 10L Kit Catalog# A14525
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of specific commercial items, namely the EXPI293 Expression Medium and the Expifectamine Transfection Kit, under solicitation number RFQ-NIAID-25-2244965. The procurement involves a total of 36 units of the expression medium to be delivered in six scheduled shipments from January to November 2025, along with one delivery of ten transfection kits, all adhering to strict quality and expiration date criteria. These products are critical for biological research and development, particularly in the fields of allergy and infectious diseases. Interested vendors must submit their proposals by October 30, 2023, via the NIH's electronic Simplified Acquisition Submission System (eSASS), and are required to be registered in the System for Award Management (SAM) prior to submission. For further inquiries, contact Calvin Robinson at calvin.robinson@nih.gov or by phone at 406-363-9214.
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Notice of Intent to Sole Source; Harris OnPoint
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Harris OnPoint Solutions for the provision of technical services related to the AcuityPlus software at the NIH Clinical Center in Bethesda, Maryland. The acquisition aims to ensure annual maintenance and support for the AcuityPlus system, which is critical for enhancing productivity and identifying best practices by comparing acuity data across organizations. As Harris OnPoint is the sole manufacturer and licenser of the AcuityPlus system, no new training is required for the nursing staff already utilizing the software. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by October 31, 2024, at 1 PM EST.